Published in Cytotherapy on January 01, 2000
Is the gene the unit of selection? Genetics (1970) 12.32
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet (2007) 6.29
A nurse is suspended. BMJ (1996) 5.93
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci (2000) 5.53
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma. Blood (2001) 4.76
Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial. Lancet (2000) 4.55
Processing mechanisms in the biosynthesis of proteins. Ann N Y Acad Sci (1980) 4.40
Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed (2001) 4.38
Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet (1997) 4.36
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Stringent spacing requirements for transcription activation by CRP. Cell (1990) 3.52
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother (1984) 3.35
Comparative genome organization of vertebrates. The First International Workshop on Comparative Genome Organization. Mamm Genome (1996) 2.97
Replication-defective vector based on a chimpanzee adenovirus. J Virol (2001) 2.86
Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunol Med Microbiol (2000) 2.80
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia (2007) 2.76
Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial. Blood (2001) 2.61
Antibiotic uptake into gram-negative bacteria. Eur J Clin Microbiol Infect Dis (1988) 2.30
HTLV-I screening in Britain. BMJ (1995) 2.25
Selection in complex genetic systems. I. The symmetric equilibria of the three-locus symmetric viability model. Genetics (1974) 2.23
Assessment of a universal, school-based hepatitis B vaccination program. JAMA (1995) 2.23
Effects of brief counselling among male heavy drinkers identified on general hospital wards. Drug Alcohol Rev (1996) 2.23
A comparison of the erythrocyte sedimentation rate and plasma viscosity in detecting changes in plasma proteins. J Clin Pathol (1977) 2.22
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol (2001) 2.20
Condom use and first-time urinary tract infection. Epidemiology (1997) 2.08
Serum free light chains for monitoring multiple myeloma. Br J Haematol (2004) 2.07
Hepatitis G virus in long-term survivors of haematological malignancy. Lancet (1996) 2.05
Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem (2000) 2.02
Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob Agents Chemother (1998) 2.00
A laboratory comparison of T cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: clinical implications for bone marrow transplantation and donor leukocyte therapy. Bone Marrow Transplant (1997) 1.96
The EBMT activity survey: 1990-2010. Bone Marrow Transplant (2012) 1.96
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood (2000) 1.93
Wessex cardiac surgery follow-up survey: the quality of life after operation. Thorax (1978) 1.93
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts. JAMA (1999) 1.92
Mechanical properties of vesicles. II. A model for osmotic swelling and lysis. Biophys J (1993) 1.89
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.88
Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant (2005) 1.86
Musculoskeletal ultrasound training in rheumatology: the Belfast experience. Rheumatology (Oxford) (2005) 1.86
Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract (2012) 1.84
Chemical synthesis and expression of a cassette adapted ubiquitin gene. J Biol Chem (1987) 1.84
The role of two surface exposed loops in transcription activation by the Escherichia coli CRP and FNR proteins. Nucleic Acids Res (1991) 1.83
Microsaccades and the velocity-amplitude relationship for saccadic eye movements. Science (1965) 1.80
Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer. J Clin Oncol (1995) 1.80
A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus (1992) 1.79
Creating a national service for the diagnosis of meningococcal disease by polymerase chain reaction. Commun Dis Public Health (1998) 1.79
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Leukemia (2011) 1.77
GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. Proc Natl Acad Sci U S A (1989) 1.73
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.72
Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. Br J Clin Pharmacol (1998) 1.72
Kawasaki disease in Canterbury. Arch Dis Child (1978) 1.70
The functional subunit of a dimeric transcription activator protein depends on promoter architecture. EMBO J (1994) 1.70
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia (2006) 1.69
Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol (1988) 1.66
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Ann Intern Med (1999) 1.65
Predictive validity of the Readiness to Change Questionnaire. Addiction (1993) 1.65
Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child (2002) 1.64
Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain. J Virol (1997) 1.64
Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem (1999) 1.62
Repression of transcriptional activity at a distance by the evolutionarily conserved KRAB domain present in a subfamily of zinc finger proteins. Nucleic Acids Res (1994) 1.60
The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis. Aliment Pharmacol Ther (2010) 1.60
Interactions between the Escherichia coli cyclic AMP receptor protein and RNA polymerase at class II promoters. Mol Microbiol (1993) 1.60
Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits. Antimicrob Agents Chemother (1999) 1.60
The structure and physiology of gastrointestinal mucus. Adv Exp Med Biol (1982) 1.59
Effect of omega-3 fatty acids on growth of a rat mammary tumor. J Natl Cancer Inst (1984) 1.59
Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience. Semin Hematol (2000) 1.59
Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival. Bone Marrow Transplant (2007) 1.53
Concordance between clinician and patient assessment of physical and mental health status. J Rheumatol (1992) 1.53
32P-incorporation PCR for the detection of rearrangements at the TCR-gamma locus. Diagn Mol Pathol (1996) 1.52
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol (1997) 1.48
Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant (2007) 1.47
Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases. J Clin Pathol (1979) 1.46
The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood (2000) 1.46
Lung function in children following repair of tracheoesophageal fistula. J Pediatr (1979) 1.46
Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome. Bone Marrow Transplant (2002) 1.46
Swimming speed distributions of bull spermatozoa as determined by quasi-elastic light scattering. Biophys J (1978) 1.46
Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol (1997) 1.45
hobo enhancer trapping mutagenesis in Drosophila reveals an insertion specificity different from P elements. Genetics (1993) 1.44
Intensive treatment of renal failure in patients with myeloma. Clin Lab Haematol (1994) 1.43
Utopia documents: linking scholarly literature with research data. Bioinformatics (2010) 1.43
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood (1995) 1.43
Migraine after bone-marrow transplantation. Lancet (1989) 1.43
Guidelines for the investigation and management of mantle cell lymphoma. Br J Haematol (2012) 1.43
The fractional shortening-velocity ratio: validation of a new echocardiographic Doppler method for identifying patients with significant aortic stenosis. J Am Coll Cardiol (1990) 1.43
Invited article: CO2 laser production of fused silica fibers for use in interferometric gravitational wave detector mirror suspensions. Rev Sci Instrum (2011) 1.42
Molecular basis for dominantly inherited inclusion body beta-thalassemia. Proc Natl Acad Sci U S A (1990) 1.42
G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial. Br J Haematol (1997) 1.42
Autoimmune thrombocytopenia in Waldenström's macroglobulinemia. Am J Hematol (2001) 1.42
Two cases of nabumetone induced pseudoporphyria. J Rheumatol (1999) 1.42
Development of polycythaemia rubra vera following treatment for centroblastic lymphoma. Acta Haematol (1996) 1.41
Role of Pseudomonas aeruginosa outer membrane protein OprH in polymyxin and gentamicin resistance: isolation of an OprH-deficient mutant by gene replacement techniques. Antimicrob Agents Chemother (1992) 1.41
Economic evaluation of peripheral blood stem cell transplantation for lymphoma. Lancet (1992) 1.40
Antifungal prophylaxis in haematology patients: the role of voriconazole. Clin Microbiol Infect (2012) 1.40